Table 2 Mean ± SD (standard deviation) and 95% CI (confidence intervals) SF-36 scores in patients and the general population*
| Â | Groups | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Â | Rheumatoid arthritis (n = 469) | Ankylosing spondilitis (n = 164) | Peripheral PsA (n = 101) | Axial PsA (n = 65) | General population (n = 1579) | |||||
|  | Mean ± SD | 95% CI | Mean ± SD | 95% CI | Mean ± SD | 95% CI | Mean ± SD | 95% CI | Mean ± SD | 95% CI |
PF | 41.8 ± 20.6 | 39.9–43.6 | 52.6 ± 21.2 | 49.4–55.9 | 43.5 ± 21.4 | 39.3–47.7 | 50.6 ± 18.6 | 46.0–55.2 | 82.5 ± 20.0 | 81.9–83.9 |
RP | 29.8 ± 16.0 | 28.3–31.2 | 38.2 ± 29.7 | 33.6–42.8 | 34.3 ± 27.3 | 28.9–39.7 | 38.4 ± 26.8 | 31.8–45.1 | 73.1 ± 36.7 | 71.3–74.9 |
BP | 30.1 ± 17.0 | 28.5–31.6 | 45.0 ± 17.4 | 42.3–47.7 | 36.3 ± 17.9 | 32.7–39.8 | 45.9 ± 16.9 | 41.8–50.1 | 78.5 ± 20.8 | 77.5–79.6 |
GH | 44.0 ± 19.7 | 42.3–45.8 | 47.2 ± 22.6 | 43.7–50.7 | 45.1 ± 16.8 | 41.8–48.5 | 43.8 ± 16.4 | 39.8–47.9 | 60.1 ± 18.1 | 59.3–61.0 |
MH | 50.3 ± 23.3 | 48.2–52.4 | 54.3 ± 20.8 | 51.1–57.5 | 44.7 ± 18.0 | 41.2–48.3 | 47.6 ± 20.6 | 42.5–52.7 | 63.6 ± 16.8 | 62.9–64.5 |
RE | 38.2 ± 41.4 | 34.4–41.9 | 42.0 ± 27.5 | 37.7–46.2 | 28.0 ± 29.7 | 22.1–33.9 | 37.6 ± 27.4 | 30.8–44.4 | 72.1 ± 38.1 | 70.2–73.9 |
SF | 46.9 ± 21.3 | 45.0–48.8 | 54.7 ± 20.9 | 51.5–58.0 | 43.1 ± 19.2 | 39.3–46.9 | 44.7 ± 11.9 | 41.7–47.7 | 71.6 ± 20.1 | 70.6–72.7 |
VT | 41.9 ± 20.8 | 40.1–43.8 | 48.5 ± 18.6 | 45.6–51.4 | 45.1 ± 15.8 | 42.0–48.3 | 41.8 ± 19.2 | 37.0–46.5 | 56.8 ± 15.4 | 56.2–57.7 |
SF-36 PCS | 32.5 ± 6.0 | 31.9–33.0 | 37.1 ± 8.6 | 35.7–38.4 | 34.1 ± 6.9 | 32.8–35.5 | 37.5 ± 7.0 | 35.8–39.2 | 49.6 ± 8.9 | 49.2–50.2 |
SF-36 MCS | 39.4 ± 11.8 | 38.3–40.5 | 40.7 ± 9.5 | 39.2–42.1 | 36.9 ± 6.8 | 35.5–38.3 | 36.5 ± 8.0 | 34.5–38.5 | 45.6 ± 8.4 | 43.1–46.1 |